Stick With ImmunityBio Inc (IBRX). The Bull Are Alive And Well
Currently, there are 853.39M common shares owned by the public and among those 91.82M shares have been available to trade. The company’s stock has a 5-day price change of 18.42% and 5.00% over the past three months. IBRX shares are trading 23.05% year to date (YTD), with the 12-month market performance down to -48.78% lower. […]
ImmunityBio Inc (NASDAQ: IBRX): The Best-Of-Breed For Investing?
Currently, there are 853.39M common shares owned by the public and among those 91.82M shares have been available to trade. The company’s stock has a 5-day price change of 5.53% and -6.32% over the past three months. IBRX shares are trading 4.30% year to date (YTD), with the 12-month market performance down to -58.41% lower. […]
An Important Check-Up On ImmunityBio Inc (NASDAQ: IBRX)
ImmunityBio Inc (IBRX) concluded trading on Thursday at a closing price of $2.60, with 6.43 million shares of worth about $16.72 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -49.02% during that period and on May 29, 2025 the price saw a gain […]
ImmunityBio Inc (IBRX): A Great Stock For Handling Current Market Conditions?
Currently, there are 853.39M common shares owned by the public and among those 91.82M shares have been available to trade. The company’s stock has a 5-day price change of 18.64% and -16.42% over the past three months. IBRX shares are trading 9.38% year to date (YTD), with the 12-month market performance down to -65.43% lower. […]
Stick With ImmunityBio Inc (IBRX). The Bull Are Alive And Well
Currently, there are 852.74M common shares owned by the public and among those 91.81M shares have been available to trade. The company’s stock has a 5-day price change of 12.38% and -30.38% over the past three months. IBRX shares are trading -7.81% year to date (YTD), with the 12-month market performance down to -70.20% lower. […]
ImmunityBio Inc (IBRX): Street Finally Waking Up
Currently, there are 852.74M common shares owned by the public and among those 91.80M shares have been available to trade. The company’s stock has a 5-day price change of -20.15% and -34.38% over the past three months. IBRX shares are trading -17.97% year to date (YTD), with the 12-month market performance down to -75.41% lower. […]
Look At Analyst Expectations For A Better Read On ImmunityBio Inc (NASDAQ: IBRX)
Currently, there are 852.74M common shares owned by the public and among those 91.80M shares have been available to trade. The company’s stock has a 5-day price change of -7.43% and -19.16% over the past three months. IBRX shares are trading -2.73% year to date (YTD), with the 12-month market performance down to -51.27% lower. […]
ImmunityBio Inc (NASDAQ: IBRX) Is Getting Increasingly Hard To Ignore
Currently, there are 852.74M common shares owned by the public and among those 91.80M shares have been available to trade. The company’s stock has a 5-day price change of -6.92% and -16.46% over the past three months. IBRX shares are trading 5.08% year to date (YTD), with the 12-month market performance down to -45.21% lower. […]
Better Times Ahead For ImmunityBio Inc (NASDAQ: IBRX)?
ImmunityBio Inc (IBRX) concluded trading on Thursady at a closing price of $5.24, with 5.31 million shares of worth about $27.82 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 208.24% during that period and on Thursady the price saw a gain of about […]
ImmunityBio Inc (IBRX): Insights At A Glance
ImmunityBio Inc (IBRX) concluded trading on Thursday at a closing price of $4.78, with 3.14 million shares of worth about $15.02 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 143.88% during that period and on Thursday the price saw a gain of about […]